(Tea Party 247) – The Israeli Pharmaceutical Company Teva has made an incredible donation to the US’ efforts to fight the coronavirus in the form of 6 million doses of chloroquine.
Teva is immediately donating 6 Million hydroxychloroquine sulfate tablets to US hospitals by March 31, with over 10 Million within a month to meet the urgent demand for the medicine as an investigational target to treat #COVID19.https://t.co/t4j8Olh324 pic.twitter.com/3U41DgzABd
— Teva Pharmaceuticals (@TevaUSA) March 20, 2020
This week, President Donald Trump called the early news of chloroquine’s effectiveness at treating the COVID-19 virus a “game-changer.”
So far, three international studies have found that treating the virus with chloroquine in combination with the antibiotic Azithromycin has been successful.
The Washington Examiner reported:
Israel’s leading drug producer announced Thursday it will donate 6 million doses of anti-malaria drugs to the United States in hopes that it could be helpful treating coronavirus symptoms.
Teva Pharmaceutical Industries says the drug could potentially treat people with the coronavirus and will ship the hydroxychloroquine tablets through wholesalers nationwide by the end of the month and will provide 10 million doses in total, according to Breitbart News.
“We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” Teva Executive Vice President Brendan O’Grady said about the move.
President Trump has expressed support and optimism for potential treatments, including malaria drugs chloroquine and hydroxychloroquine.
Earlier this week, The Gateway Pundit reported:
President Trump made the announcement at the daily Coronavirus press conference in the White House. The president added that chloroquine has shown, “very, very encouraging results” in treating the coronavirus!
New York Governor Cuomo has agreed to start using the drug in his state immediately!
On Monday Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, announced that the first trial vaccine for the coronavirus is now being tested. The trial taking place in Seattle, which has been a hotbed for COVID-19. The test includes 45 people age 18-55 and they are receiving two injections, one at zero days, one at 28 days. The individuals will then be followed for one year. The trial results is still months away.